Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
1 study found for:    8443385 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed Daclizumab to Treat Chronic Immune Thrombocytopenia
Condition: Thrombocytopenia
Intervention: Drug: Daclizumab

Study has passed its completion date and status has not been verified in more than two years.